Trials / Recruiting
RecruitingNCT07238816
A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People
A Single-centre, Open-label, Randomised, Single-dose Study to Evaluate the Effect of Pre- and Post-dose Meal Timings on the Pharmacokinetic Properties of Inno8 in Healthy Participants
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to test a new medicine called Inno8. The study will test how eating and drinking before and after taking Inno8 affects how well it is absorbed in the stomach. The study consists of four arms. Participants will take the study medicine after an overnight fast. How long participants will need to fast depends on which group participants are in. After taking the study medicine, participants will need to fast again. The study will last for up to 9.5 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NNC0442-0344 A | NNC0442-0344 A will be administered orally. |
Timeline
- Start date
- 2025-11-18
- Primary completion
- 2026-04-29
- Completion
- 2026-04-29
- First posted
- 2025-11-20
- Last updated
- 2025-12-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07238816. Inclusion in this directory is not an endorsement.